Please assess the completion status of the following clinical trial:

Trial Title: Imaging Airway Liquid Absorption in Cystic Fibrosis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult healthy control arm:~  * subjects 18 years old or older without a diagnosis of lung disease.~* Pediatric CF arm:~  * subjects 6-14 years with a diagnosis of cystic fibrosis as determined by sweat test or genotype~ * subjects who are clinically stable as determined by the pediatrician co-investigator~ * subjects must have a previously demonstrated ability to perform reproducible pulmonary function testing based on previous clinical visits.~* Females in all groups who are of child-bearing potential will need to have a negative urine pregnancy test.~Exclusion Criteria:~* Adult healthy control arm:~  * FEV1%p \< 80% of predicted~ * nursing mother~ * positive urine pregnancy test or unwilling to test~ * cigarette smoker (regular smoking within 6 months of study).~* Pediatric CF arm:~  * FEV1%p \< 40% of predicted~ * nursing mother~ * positive urine pregnancy test for females of childbearing potential~ * unable or unwilling to comply with test procedure~ * cigarette smoker (regular smoking within 6 months of study).~ * Subjects unable to lie recumbent without moving for the 80 minute imaging period will be excluded.

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- CF pediatric (Type: EXPERIMENTAL): In the pediatric arm 10 CF subjects ages 6-14 will perform absorptive clearance scans at baseline and at t=2 years.
- Controls adult (Type: EXPERIMENTAL): In the adult control arm 10 healthy adult subjects will perform a single absorptive clearance scan.

Based on this trial design, predict the completion outcome and termination type (if applicable).